Evidence map›Paper›PMID 38738076›Full record

ArticleCureus2024

Jaundice and Higher Procalcitonin Level Revealing a Small-Cell Lung Cancer With Pancreatic Metastasis: A Case Report From Eastern Morocco.

Hind Chibani, Soufia El Ouardani, Mouhsine Omari, Karich Nassira, Ouissam Al Jarroudi, Hanane Hadj Kacem, Sami Aziz Brahmi, Amal Bennani, Said Afqir

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hind ChibaniMedical Oncology, Mohammed VI University Hospital, Oujda, MAR.
Soufia El OuardaniMedical Oncology, Mohammed VI University Hospital, Oujda, MAR.
Mouhsine OmariMedical Oncology, Mohammed VI University Hospital, Oujda, MAR.
Karich NassiraPathology, Mohammed VI University Hospital, Oujda, MAR.
Ouissam Al JarroudiMedical Oncology, Mohammed VI University Hospital, Oujda, MAR.
Hanane Hadj KacemRadiology, Mohammed VI University Hospital, Oujda, MAR.
Sami Aziz BrahmiMedical Oncology, Mohammed VI University Hospital, Oujda, MAR.
Amal BennaniPathology, Mohammed VI University Hospital, Oujda, MAR.
Said AfqirMedical Oncology, Mohammed VI University Hospital, Oujda, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small-cell lung cancer (SCLC) is highly aggressive, with a severe tendency for metastasis. Pancreatic metastasis in SCLC is uncommon, also jaundice as a major symptom of small-cell lung cancer is even rarer. The diagnosis of pancreatic metastasis is a real challenge for the medical team, it relies on both radiological and pathological details. We report a case of a 58-year-old male admitted for SCLC with pancreatic metastasis and a higher level of procalcitonin. He received platinum-based chemotherapy with a swell response. The focus of this study will be on the characteristics of pancreatic metastasis, along with their diagnosis and treatment approaches. Procalcitonin as a paraneoplastic syndrome will also be discussed in this study.

Indexed as

jaundicemetastatic non-small-cell lung cancerpancreatic metastasisplatinum-based chemotherapyprocalcitonin

Identifiers

PMID38738076
PMCPMC11088360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.